Mid Atlantic Bio Angels

NEW YORK CITY, NEW YORK, UNITED STATES, November 10, 2022 /EINPresswire.com/ — Mid Atlantic Bio Angels Group (MABA) is pleased to announce that it has made an investment in The Shape Sensing Company (TSSC).

TSSC joins a prestigious, carefully selected, group of companies and organizations that reflects MABA’s core mission of supporting early-stage health care entrepreneurs and generating favorable financial returns for its members and investors. The MABA investment included individual investors, MABA’s internal investment Pool III, and the MABA Sidecar Fund II, a co-investment fund for non-MABA members.

“Throughout our due diligence process, TSSC’s strong management and transformative technology received notable [ Read more… ]

FEMSelect, a company developing EnPlace, a minimally invasive and meshless device for women with pelvic floor issues, raises $9M in Series B funding with participation from Mid Atlantic Bio Angels.

Link to article: https://www.prnewswire.com/news-releases/womens-health-leader-femselect-secures-us9m-series-b-financing-301652846.html

MABA founder Yaniv Sneor participates on an Angel Investors Panel at Digital RESI 2020 where he discusses several topics including what angels (and MABA) look for in a company, how angels prefer to invest (priced rounds, not SAFEs), and the benefits of syndication.

Link to article: https://blog.lifesciencenation.com/2022/07/14/from-mid-size-pharma-to-angels-what-do-investors-say-about-market-downturn/

Link to release

Read article below:

Link to release

Read article below:

MABA portfolio company, Healionics, wins the 2020 Luis Villalobos Award from the Angel Capital Association (ACA). The Luis Villalobos Award recognizes ingenious and innovative ideas financed by members of the ACA. Healionics is developing a product to make dialysis safer for those with kidney failure.

Link to document